Profil
Michael Molyneaux worked as the Chief Medical Officer at Macrocure Ltd.
from 2013 to 2015.
He holds an MBA from Washington University in St. Louis, a doctorate from Dalhousie University, and an undergraduate degree from the University of Prince Edward Island.
Anciens postes connus de Michael Molyneaux
| Sociétés | Poste | Fin |
|---|---|---|
| MACROCURE LTD | Directeur Technique/Scientifique/R&D | 31/12/2015 |
Formation de Michael Molyneaux
| Washington University in St. Louis | Masters Business Admin |
| University of Prince Edward Island | Undergraduate Degree |
| Dalhousie University | Doctorate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 1 |
|---|---|
Macrocure Ltd.
 Macrocure Ltd. Medical SpecialtiesHealth Technology Macrocure Ltd. is a clinical-stage biotechnology company, which engages in the development and commercialization of advanced cell therapy products. Its product, CureXcell, is an advanced wound care therapy that treat such wounds by injecting living human white blood cells that have been activate to facilitate the healing process. The company was founded by David Ben-Ami on January 14, 2008 and is headquartered in Petach Tikva, Israel. | Health Technology |